Cook Indiana plant gets FDA approval for vial filling

Milestones are great, whether they come in the form of payments or, in the case of Cook Pharmica, the first FDA approval to manufacture commercially.

Catching up with some of its competitors, the contract development and manufacturing company says the FDA in February inspected the new vial fill finish line, freeze-drying capabilities and facility-wide quality systems at its plant in Bloomington, IN, and has now given the plant the thumbs-up. "This FDA decision marks a very important milestone for our company," says Tedd Green, president of Cook Pharmica.

Based on experience, the company says it expects the FDA approval is a precursor to getting approval to seek similar approvals to manufacture drugs for overseas markets.

The $200 million, 900,000-square-foot plant in Bloomington has vial and prefilled syringe manufacturing lines under barrier isolation, as well as secondary packaging. It can fill up to 15 million vials and 70 million prefilled syringes a year. The company has about 400 employees.

Fill finish has become a hot area in the contract manufacturing arena, with a number of companies expanding lines. 

- here's the press release

Suggested Articles

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.

GE is launching its prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines.